Related Experiment Video
Updated: Aug 29, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Multiple molecular-genetic defects in a woman with mixed hyperlipoproteinemia and early ischemic heart disease]
Insights
Genetic analysis revealed that a combination of apolipoprotein E (apoE), LDLP receptor, and methylenetetrahydrofolate reductase (MTHFR) gene variations may contribute to early ischemic heart disease (IHD) in women.
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Atherosclerosis Research
Background:
- Mixed hyperlipoproteinemia (HLP) and early ischemic heart disease (IHD) present significant health challenges.
- Genetic predisposition plays a crucial role in the development of cardiovascular diseases.
- Understanding gene-environment interactions is key to personalized medicine.
Observation:
- A female patient with mixed HLP and early IHD underwent genetic analysis.
- The study examined polymorphisms in the apolipoprotein E (apoE), LDLP receptor, and methylenetetrahydrofolate reductase (MTHFR) genes.
- The patient exhibited variations in all three genes: LDLP receptor A370T, MTHFR C677T, and apoE epsilon 2/epsilon 2 genotype.
Findings:
- The proband presented with a unique combination of three genetic polymorphisms.
- None of the examined relatives carried more than one of these specific gene variations.
- This suggests a potential synergistic effect of these polymorphisms in disease development.
Implications:
- The findings highlight the potential role of combined gene polymorphisms in the etiology of early-onset IHD in females.
- This genetic insight could inform risk stratification and personalized prevention strategies for atherosclerosis.
- Further research is warranted to elucidate the precise mechanisms linking these gene variants to IHD.
Aim:
Analysis of genes of apolipoprotein E (apoE), LDLP receptor and methylentetrahydrofolate reductase (MTHFR) in a female patient with mixed hyperlipoproteinemia (HLP) and early ischemic heart disease (IHD).
Material And Methods:
A patient with a mixed form of HLP and 5 her relatives were examined genetically. The genotype of apoE and MTHFR was determined using a restrictive analysis of PCR fragments. Conformation of one chain DNA was used to analyse gene of LDLP-receptor with following sequencing of anomalous DNA.
Results:
The proband had changes in all examined genes: nucleotide replacement of A370T gene of LDLP receptor, nucleotide replacement of MTHFR gene C677T and epsilon 2/epsilon 2-genotype of apoE. None of the relatives carried more than one polymorphism by the studied genes.
Conclusion:
Early IHD in females can be caused by combination of polymorphisms of genes associated with development of atherosclerosis.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
